NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Creyon Bio

Creyon Bio

Private
San Diego, CaliforniaHealthcare & Life Scienceshttps://creyon.com/

Last Round

Strategic

Apr 29, 2025

Total Funding Raised

$40M

Company Overview

Creyon Bio is a biotechnology company that develops RNA-based medicines and their components using a data-first approach with machine learning models.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Infrastructure

Keywords

AI drug discoveryRNA therapiesoligonucleotide therapiesdrug discovery platformtechbiooligo therapiespharma partnershipsoligo engineeringgenerative biologyquantum chemistryprecision medicineoligonucleotide-based medicinesOBMsaptamer delivery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Creyon Bio Comps

Public and private peers based on sector, stage, and business model.

Creyon Bio comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Creyon Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
StrategicApr 29, 2025
SeedMar 8, 2022

Key People

Founding team and executive leadership

Serge Messerlian

Acting CEO And Executive Chairman

Executive Team

Jason Ferrone

Chief Operating Officer And General Counsel

Executive Team

Creyon Bio Investors

Notable investors and investment history

Creyon Bio investors
InvestorRounds
DCVC BioSeed
Lux CapitalSeed
Alexandria Venture InvestmentsSeed
BioBritSeed
Casdin CapitalSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 29, 2025

    Completed a strategic funding round.

  • Mar 8, 2022

    $40M raised in Seed round.

Creyon Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Creyon Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Creyon Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Diego, California
Employee Range31
Year Founded2019
Last FundingApr 29, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.